Calling for an annual FDA report on the RACE for Children Act PolicySteve WosahlaOctober 30, 2024RACE Act, drug development, new therapies
First Two Years of the RACE Act Evaluated in New GAO Report PolicySteve WosahlaFebruary 8, 2023RACE Act, drug development, new therapies
The RACE for Children Act Now in Full Effect PolicyJessica KeanAugust 18, 2020RACE Act, FDA, drug development
RACE Act Implementation: Our Comments on Draft Guidance ResearchJessica KeanJanuary 23, 2020RACE Act, PREA, FDARA, drug development